Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gynecology

Free Subscription 03.11.2025 1 Acta Obstet Gynecol Scand 5 Am J Obstet Gynecol 4 Anticancer Res 3 BMC Cancer 1 Clin Cancer Res 1 Eur J Cancer 13 Eur J Obstet Gynecol Reprod Biol 2 Fertil Steril 2 Gynecol Endocrinol 8 Gynecol Oncol 3 Hum Reprod 19 Int J Gynaecol Obstet 1 J Clin Endocrinol Metab 4 JAMA 1 Lancet 2 Obstet Gynecol 6 PLoS One 1 Proc Natl Acad Sci U S A 1 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. KNORREN ER, Schutte JM, Huirne JAF, Boomsma MF, et al
   Understanding clinical outcomes of MR-HIFU treatment of uterine fibroids by gaining insight in screening protocols.
   Acta Obstet Gynecol Scand. 2025 Oct 29. doi: 10.1111/aogs.70087.
   PubMed        
   
   

   
   Am J Obstet Gynecol

2. SCHAAFSMA M, Schuurman TN, van Maurik IS, Bekkers RLM, et al
   Optimal follow-up strategy using high-risk HPV testing and cytology after conservative treatment for cervical adenocarcinoma in situ.
   Am J Obstet Gynecol. 2025 Jun 5:S0002-9378(25)00367.
   PubMed         Abstract available
   
   
3. ERIKSEN DO, Lycke KD, Kahlert J, Ostenfeld EB, et al
   Active surveillance of cervical intraepithelial neoplasia grade 2 is not associated with an increased risk of non-cervical anogenital HPV-related cancer and precancer a population-based cohort study.
   Am J Obstet Gynecol. 2025 Jun 3:S0002-9378(25)00366.
   PubMed         Abstract available
   
   
4. VIDA B, Lintner B, Veres DS, Varbiro S, et al
   Assessing the comparative efficacy of sentinel lymph node detection techniques in vulvar cancer: a systematic review and meta-analysis.
   Am J Obstet Gynecol. 2025;233:363-379.
   PubMed         Abstract available
   
   
5. POLITI S, Ghi T
   Hypoxic-ischemic encephalopathy following intrapartum asphyxia: not always preventable if the admission test looks normal (Letter-to-the-Editor).
   Am J Obstet Gynecol. 2025 Oct 28:S0002-9378(25)00805.
   PubMed        
   
   
6. LABARRERE CA, Romero R, Dicarlo HL, Hardin JW, et al
   Evidence that atherosis of the spiral artery represents atherosclerotic lesions similar to those of native and transplant-induced atherosclerosis: implications for understanding the pathophysiology of obstetrical syndromes and long-term cardiovascular
   Am J Obstet Gynecol. 2025 Oct 22:S0002-9378(25)00764.
   PubMed         Abstract available
   
   

   
   Anticancer Res

7. DELL'ATTI L
   Management of Bladder Cancer During Pregnancy: A Narrative Review.
   Anticancer Res. 2025;45:4689-4695.
   PubMed         Abstract available
   
   
8. ITO Y, Nakamura K, Nakagawa-Saito Y, Takenouchi S, et al
   Senolytic Elimination of Senescent Ovarian Clear Cell Carcinoma Cells Induced by CEP-1347 With the BH3 Mimetic Navitoclax.
   Anticancer Res. 2025;45:4841-4851.
   PubMed         Abstract available
   
   
9. YOO SS, Banish K, Fahmi A, Glasener C, et al
   Focused Ultrasound-mediated Disruption of Plasma Protein Binding Enhances Chemotherapeutic Effects of Paclitaxel on Xenografted Ovarian Cancer in Mice.
   Anticancer Res. 2025;45:4697-4715.
   PubMed         Abstract available
   
   
10. ITO Y, Nakamura K, Nakagawa-Saito Y, Suzuki S, et al
    The MDM4 Inhibitor CEP-1347 Activates Wild-type p53 in Ovarian Clear Cell Carcinoma Cells and Potently Inhibits their Growth.
    Anticancer Res. 2025;45:4881-4890.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. LI N, Yu Z, Li X, Gao Y, et al
    The rationality of negative margin criteria for conization in early cervical cancer - a cohort study.
    BMC Cancer. 2025;25:1640.
    PubMed         Abstract available
    
    
12. ABUBAKAR BG
    Taking it to their doorstep: outreach well-woman clinics in brothels for cervical cancer screening of female sex workers in North-Western Nigeria.
    BMC Cancer. 2025;25:1660.
    PubMed         Abstract available
    
    
13. TRAN NL, Wang Y, Quinn KM, Bilandzic M, et al
    Podocalyxin protects high grade serous ovarian cancer spheroids from NK cell infiltration and spheroid destruction.
    BMC Cancer. 2025;25:1674.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

14. VENEGAS L, Hodgson A, Oza AM
    Biomarkers in High-Grade Serous Ovarian Cancer: Context is everything.
    Clin Cancer Res. 2025 Oct 30. doi: 10.1158/1078-0432.CCR-25-2851.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

15. LOMBAERS MS, Reijnen C, Sprik A, Bretova P, et al
    ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.
    Eur J Cancer. 2025;231:116058.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

16. BARTELS HC, Horsch A, Cooney N, Brennan DJ, et al
    Caesarean scar pregnancy: Parents lived experience.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114779.
    PubMed         Abstract available
    
    
17. SINGHAL S, Rajan S, Khurana S, Kumari R, et al
    Reproductive outcomes following chemotherapy for gestational trophoblastic neoplasia: experience from a tertiary care center.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114774.
    PubMed         Abstract available
    
    
18. ZHOU J, Qiao C, Yan L, Yan L, et al
    The rise of intrauterine adhesion research: Insights into global contributions and future directions.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114787.
    PubMed         Abstract available
    
    
19. SRIVASTAVA A, Mallik R, Sharma LK, Rani A, et al
    Diagnostic utility of Synuclein gamma (SNCG) and b-cell Lymphoma 6 (BCL6) as potential non-invasive dual biomarkers for endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2025;315:114778.
    PubMed         Abstract available
    
    
20. CASANOVA J, Ramos AS, Babiciu A, Moutinho F, et al
    Prevalence of high-grade endometrioid endometrial cancer of no specific molecular profile (NSMP): A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114794.
    PubMed         Abstract available
    
    
21. GRASSO I, Barranco R, Ferrero S, Ventura F, et al
    Medico-legal litigation in obstetrics and gynecology: an eleven-year case series and comparison of out-of-court resolution and legal proceedings.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114795.
    PubMed         Abstract available
    
    
22. RAM S, Gilboa I, Ariel G, Sabag DN, et al
    Risk factors for hospital readmission following staging surgery for endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114792.
    PubMed         Abstract available
    
    
23. ROMANO A, Friedrich L, Zeevi G, Bor N, et al
    The relationship between first-trimester progesterone treatment and gestational diabetes.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114791.
    PubMed         Abstract available
    
    
24. KANERVA J, Svensson M, Hagman A, Berg M, et al
    Management of women with retained placenta and the risk of postpartum haemorrhage: A retrospective cohort study from a Swedish single centre.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114785.
    PubMed         Abstract available
    
    
25. DICK A, Lessans N, Cohen N, Gutman-Ido E, et al
    Distinguishing mature from immature ovarian teratoma in the pre-operative setting.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114793.
    PubMed         Abstract available
    
    
26. MAJEWSKA A, Seed PT, Chambers J, Dixon PH, et al
    Stillbirth in intrahepatic cholestasis of pregnancy and timing of severely elevated bile acid concentrations: an observational cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114800.
    PubMed         Abstract available
    
    
27. CAI J, Li Q
    Mendelian randomization analysis of the causal links between immune cells, metabolites, and ectopic pregnancy.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114797.
    PubMed         Abstract available
    
    
28. MATSUZAKI S, Canis M
    Effects of hormonal treatment on the expression of collagen type I, matrix metalloproteinase-1, and tissue inhibitor of metalloproteinases-1 in endometriosis.
    Eur J Obstet Gynecol Reprod Biol. 2025;316:114788.
    PubMed         Abstract available
    
    

    
    Fertil Steril

29. AASE DA, Khan Z
    Isthmocele: one problem, many faces.
    Fertil Steril. 2025;124.
    PubMed         Abstract available
    
    
30. HANSTEDE MMF, Veersema S, Emanuel MH, Vollebregt K, et al
    "The threat of Asherman syndrome": a propensity score-matched study of fetal-maternal outcomes.
    Fertil Steril. 2025;124.
    PubMed         Abstract available
    
    

    
    Gynecol Endocrinol

31. NING B, Zhang M, Su N, Bur R, et al
    Global, regional, and national burden of polycystic ovary syndrome, 1990-2021: a comprehensive analysis of trends and projections based on the global burden of disease 2021 study.
    Gynecol Endocrinol. 2025;41:2535737.
    PubMed         Abstract available
    
    
32. WANG Z, You Y, Jun L, Long X, et al
    Factors influencing the occurrence of pre-eclampsia and the establishment of a risk prediction model: a retrospective study.
    Gynecol Endocrinol. 2025;41:2574870.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

33. MANNING B, Banerjee S, Hawkins TB, Winn-Deen ES, et al
    Extracellular vesicle and particle-based blood test for ovarian cancer screening of average risk population: a promising nested case control study using preclinical samples.
    Gynecol Oncol. 2025;203:26-34.
    PubMed         Abstract available
    
    
34. ANDRES S, Tannous A, Kahn RM, Yeoshoua E, et al
    Survival outcomes in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer: Does the indication for neoadjuvant chemotherapy matter?
    Gynecol Oncol. 2025;203:35-42.
    PubMed         Abstract available
    
    
35. TEWARI S, Koelker-Wolfe E, Pelletier A, St Laurent J, et al
    The impact of romiplostim use for chemotherapy induced thrombocytopenia on immediate and long-term outcomes in gynecologic malignancies.
    Gynecol Oncol. 2025;203:53-58.
    PubMed         Abstract available
    
    
36. SKOLD C, Radestad AF, Bohlin KS, Bjurberg M, et al
    Primary treatment and survival in malignant ovarian germ cell tumors: A nationwide population-based Swedish Gynecologic Cancer Group (SweGCG) study.
    Gynecol Oncol. 2025;203:59-66.
    PubMed         Abstract available
    
    
37. WANG Y, Li J, Yang Y, Lu X, et al
    Letrozole plus anlotinib as a chemotherapy-free regimen for ER-positive platinum-resistant recurrent epithelial ovarian cancer patients following second-line platinum-based chemotherapy failure: A prospective, single-arm, open-label, phase II study.
    Gynecol Oncol. 2025;203:67-74.
    PubMed         Abstract available
    
    
38. XU X, Chen L, Nunez-Smith M, Clark M, et al
    Postmenopausal bleeding: Association of initial place of care with stage at diagnosis for uterine cancer.
    Gynecol Oncol. 2025;203:75-83.
    PubMed         Abstract available
    
    
39. ARAUJO LW, Maliniak ML, Barber LE, Dilley SE, et al
    Neighborhood socioeconomic status and endometrial cancer mortality: Racial disparities persist across the spectrum.
    Gynecol Oncol. 2025;203:84-89.
    PubMed         Abstract available
    
    
40. LINDGREN A, Benseler A, Hogen L, May T, et al
    Description of first recurrence in advanced stage high grade serous ovarian cancer receiving intraperitoneal versus intravenous systemic treatment.
    Gynecol Oncol. 2025;203:90-96.
    PubMed         Abstract available
    
    

    
    Hum Reprod

41. CUNY H, Shand AW, Goth J, Sheng DZ, et al
    Identification of potential NAD-related biomarkers of recurrent miscarriage risk.
    Hum Reprod. 2025 Oct 31:deaf195. doi: 10.1093.
    PubMed         Abstract available
    
    
42. 
    Correction to: O-020 Impact of an oral antioxidant supplement in men on semen quality and pregnancy rates, results of a multicentre, randomised, triple-blind, placebo-controlled trial (SUMMER trial).
    Hum Reprod. 2025 Oct 28:deaf213. doi: 10.1093.
    PubMed        
    
    
43. KIESLINGER DC, Vergouw CG, von Estorff F, Ramos L, et al
    Obstetric and perinatal outcomes from the follow-up of a multicentre randomized controlled trial investigating time-lapse embryo monitoring.
    Hum Reprod. 2025 Oct 26:deaf197. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

44. ULGER G, Yildiz H, Akay K, Yildizbakan A, et al
    Is systemic inflammation associated with reduced ovarian reserve in endometriosis? An investigation of anti-Mullerian hormone and inflammatory markers.
    Int J Gynaecol Obstet. 2025 Oct 24. doi: 10.1002/ijgo.70610.
    PubMed         Abstract available
    
    
45. WALSH H, Bibby P, Redler K, Mtunzi N, et al
    When is the optimal time to remove uterine compression balloons? An 11-year retrospective cohort study.
    Int J Gynaecol Obstet. 2025 Oct 25. doi: 10.1002/ijgo.70559.
    PubMed         Abstract available
    
    
46. YAN Q, Lu J, Yu M, Qian Y, et al
    Influencing factors to self-management among women with hypertensive disorders of pregnancy: A qualitative systematic review using the COM-B model.
    Int J Gynaecol Obstet. 2025 Oct 27. doi: 10.1002/ijgo.70575.
    PubMed         Abstract available
    
    
47. TARIQ S, Kumar P, Keenan O, Harrity C, et al
    Pyomyoma outside of pregnancy-Case report and systematic review of the literature.
    Int J Gynaecol Obstet. 2025 Oct 27. doi: 10.1002/ijgo.70616.
    PubMed         Abstract available
    
    
48. OPOKU MENSAH B, Anim E, Ahenkorah Fondjo L, Gyan B, et al
    Diagnostic performance of urinary adipsin as a screening biomarker for pre-eclampsia.
    Int J Gynaecol Obstet. 2025 Oct 27. doi: 10.1002/ijgo.70619.
    PubMed         Abstract available
    
    
49. WEST M, Alsaidi A, Siddiqi R, Sayyed F, et al
    Artificial intelligence in obstetrics and gynecology: Evaluating ChatGPT and Google Gemini in answering patient questions.
    Int J Gynaecol Obstet. 2025 Oct 28. doi: 10.1002/ijgo.70622.
    PubMed         Abstract available
    
    
50. BOZKURT OZDAL B, Tanacan A, Akgun Aktas B, Okutucu G, et al
    First-trimester HALP score as a predictor of placental abruption and adverse outcomes.
    Int J Gynaecol Obstet. 2025 Oct 28. doi: 10.1002/ijgo.70602.
    PubMed         Abstract available
    
    
51. MELEKOGLU R, Erenler AS, Kiran TR, Inceoglu F, et al
    The role of carbonic anhydrase I and II enzymes in the pathogenesis of gestational diabetes mellitus and their relationship with oxidative stress.
    Int J Gynaecol Obstet. 2025 Oct 29. doi: 10.1002/ijgo.70591.
    PubMed         Abstract available
    
    
52. UBERTI EMH, de Freitas Medeiros LR, Reis RJ, Poli JH, et al
    Successful pregnancy following fertility-sparing surgery for placental site trophoblastic tumor.
    Int J Gynaecol Obstet. 2025 Oct 30. doi: 10.1002/ijgo.70642.
    PubMed        
    
    
53. CHAWLA L, Chaturvedi J, Rajaram S, Pooja, et al
    GnRH agonist-induced ovarian hyperstimulation: A diagnostic clue to pituitary adenoma.
    Int J Gynaecol Obstet. 2025 Oct 31. doi: 10.1002/ijgo.70643.
    PubMed        
    
    
54. SHEN H, Hu H, Li J
    Letter to the editor: Pregnancy outcomes following different surgical approaches for heterotopic interstitial and angular pregnancy.
    Int J Gynaecol Obstet. 2025 Nov 1. doi: 10.1002/ijgo.70630.
    PubMed        
    
    
55. DIKGALE B, Dlakavu F, Masenge A, De Gouveia S, et al
    Response to letter to the editor: Pregnant women's dietary patterns and knowledge of gestational weight gain: A cross-sectional study.
    Int J Gynaecol Obstet. 2025 Nov 1. doi: 10.1002/ijgo.70634.
    PubMed        
    
    
56. SAHEBARI M, Zare H
    Letter to the editor: Prediction of postoperative abdominal distension in patients undergoing gynecologic laparoscopic surgery: A cross-sectional study.
    Int J Gynaecol Obstet. 2025 Nov 1. doi: 10.1002/ijgo.70631.
    PubMed        
    
    
57. PECORELLA G, Tinelli A
    Response: Laparoscopic repair of uterine rupture after delivery: A comprehensive evaluation of the uterine rupture management, with a proposal surgical method.
    Int J Gynaecol Obstet. 2025 Nov 1. doi: 10.1002/ijgo.70629.
    PubMed        
    
    
58. LABAN M, Hassanin AS, Hussain SH, Elsayed JT, et al
    Accuracy of endomyometrial biopsy in diagnosis of adenomyosis: A prospective study.
    Int J Gynaecol Obstet. 2025;171:705-710.
    PubMed         Abstract available
    
    
59. O'HIGGINS LA, Davies E, Javed A
    Vulval ulceration as a first presentation of systemic lupus erythematosus: A case report and literature review.
    Int J Gynaecol Obstet. 2025;171:646-650.
    PubMed         Abstract available
    
    
60. MARSHALL A, Pareja R, Ruzindana K, Bhatla N, et al
    FIGO position statement on the effectiveness and safety of the HPV vaccine.
    Int J Gynaecol Obstet. 2025 Sep 3. doi: 10.1002/ijgo.70506.
    PubMed         Abstract available
    
    
61. DIAZ I, Lumsden MA, Zeppernick M
    Medical treatment of fibroids: FIGO best practice guidance.
    Int J Gynaecol Obstet. 2025;171:507-512.
    PubMed         Abstract available
    
    
62. TOPCU EG, Hull ML, Nelson S, Mocanu E, et al
    FIGO Fertility Passport: A tool for patients and their healthcare providers.
    Int J Gynaecol Obstet. 2025;171:513-516.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

63. LIANG X, Han H, Shen X, Williams PL, et al
    Hair mercury levels, serum n-3 fatty acids, and pregnancy glucose outcomes among women from a fertility center.
    J Clin Endocrinol Metab. 2025 Oct 29:dgaf594. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    JAMA

64. POLSKY S
    Automated Insulin Delivery in Pregnancy.
    JAMA. 2025 Oct 24. doi: 10.1001/jama.2025.19201.
    PubMed        
    
    
65. DONOVAN LE, Lemieux P, Dunlop AD, Yamamoto JM, et al
    Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial.
    JAMA. 2025 Oct 24:e2519578. doi: 10.1001/jama.2025.19578.
    PubMed         Abstract available
    
    
66. DONLEY G, Grossman LA, Zettler PJ
    State Mifepristone Regulation Following GenBioPro v Raynes.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.19752.
    PubMed        
    
    
67. SULLIVAN HK, Sinaiko AD, Fox K, Armstrong JC, et al
    Stillbirths in the United States.
    JAMA. 2025 Oct 27:e2517392. doi: 10.1001/jama.2025.17392.
    PubMed        
    
    

    
    Lancet

68. ALLEMANI C, Minicozzi P, Morawski B, Lima CA, et al
    Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39
    Lancet. 2025 Oct 22:S0140-6736(25)01383-2. doi: 10.1016/S0140-6736(25)01383.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

69. LARKIN S, Muir C, Vollrath L, Allison BA, et al
    Anticipation and Experience of Pain During Intrauterine Device Placement.
    Obstet Gynecol. 2025 Oct 30. doi: 10.1097/AOG.0000000000006109.
    PubMed         Abstract available
    
    
70. PANELLI DM, Esmaeili A, Joyce VR, Chan CS, et al
    Association Between Mental Illness and Risk of Severe Maternal Morbidity in Pregnant Veterans.
    Obstet Gynecol. 2025 Oct 30. doi: 10.1097/AOG.0000000000006107.
    PubMed         Abstract available
    
    

    
    PLoS One

71. YANG S, Liu L, Su Q, Wang J, et al
    Construction of a prognostic prediction model for concurrent radiotherapy in cervical cancer using GEO and TCGA databases with preliminary validation analysis.
    PLoS One. 2025;20:e0334281.
    PubMed         Abstract available
    
    
72. KIANI Z, Simbar M, Nazarpour S, Ghasemi V, et al
    Dignity-based care and infertility treatment: A qualitative study.
    PLoS One. 2025;20:e0334322.
    PubMed         Abstract available
    
    
73. MORSKY MK, Kaartinen IS, Nyberg RH
    Electrothermal bipolar vessel sealing devices are associated with lower rates of postoperative complications compared to ultrasonic devices in vulvar cancer surgery.
    PLoS One. 2025;20:e0335266.
    PubMed         Abstract available
    
    
74. HUERTA-SAQUERO A, Nefedova E, Shkil NN, Pestryakov A, et al
    AgNPs treatment reduces time recovery and increases bacterial sensitivity to antibiotics in cow s purulent catarrhal endometritis. A translational study.
    PLoS One. 2025;20:e0335305.
    PubMed         Abstract available
    
    
75. YOUNAS S, Malik ZI, Khan MU, Manzoor S, et al
    Identification of novel therapeutic inhibitors against E6 and E7 oncogenes of HPV-16 associated with cervical cancer.
    PLoS One. 2025;20:e0323595.
    PubMed         Abstract available
    
    
76. BEN TAHER Y, Ben Rekaya M, Romdhane E, Miladi B, et al
    HPV testing in cervical cancer formalin-fixed paraffin embedded tissues: Reliability of the Xpert HPV test and high-risk HPV genotypes distribution in Tunisia.
    PLoS One. 2025;20:e0333600.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

77. MARQUARDT RM, Grimm SA, Wu SP, Lais PF, et al
    Serum response factor is essential for endometrial function and prevention of inflammatory fibrosis.
    Proc Natl Acad Sci U S A. 2025;122:e2510060122.
    PubMed         Abstract available
    
    

    
    Urology

78. CHAVEZ JM, Christie AL, Zimmern PE
    Comparison of D-mannose in Foods with Urine pH in Post-Menopausal Women with Recurrent Urinary Tract Infections.
    Urology. 2025 Oct 29:S0090-4295(25)01032-5. doi: 10.1016/j.urology.2025.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.